Skip to main content

CANTOR FITZGERALD, L. P.

Position in IMCR — Immunocore Holdings plc

CIK 1024896 NEW YORK, NY

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,543,861
+$7,543,861 QoQ
Shares Held
250,211
Ownership
0.492%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in IMCR Over Time

Shares Held

Position Value (USD)

Derivatives in IMCR

reported options exposure · as of Mar 31, 2026
CallValue
$1,522,575
CallShares
50,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CANTOR FITZGERALD, L. P. holds $25,602,427 across 21 Biotechnology names. IMCR ranks #1 (29.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMCR
Immunocore Holdings plc
This page
250,211 $7,543,861

All Filings in IMCR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,522,575 50,500
2026-03-31 $7,543,861 250,211
2025-12-31 $1,752,855 50,500
2025-09-30 $2,724,750 75,000
2025-06-30 $784,531 25,001
2025-06-30 $2,353,500 75,000
2025-03-31 $2,967,000 100,000
2024-09-30 $3,173,454 101,942
2024-06-30 $8,608,975 254,027